AnnouncementsAstraZeneca Pharma India: Outcome of board meeting
AnnouncementsAstraZeneca Pharma India: Board to consider dividend
100% of moneycontrol users recommend buying AstraZeneca.
What's your call on AstraZeneca today?
Read 3 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2733.95||0.54||2939.80||2140.35||46,568.75|
|Dec' 13||Sep' 13||Jun' 13||May' 13|
Vaibhav Global Recommended on Jun 11th 2014
Recommended price 675.00 | Peak from reco 910.00 34.81%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
AstraZeneca is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,839.88 crore.The company has reported a standalone sales of Rs 114.15 crore and a Net Loss of Rs -2.57 crore for the quarter ended Mar 2014.
The company management includes D E Udwadia - Chairman, Sanjay Murdeshwar - Managing Director, Robert Ian Haxton - Whole Time Director, Narayan K Seshadri - Director, Ian Brimicombe - Director.
It is listed on the BSE with a BSE Code of 506820 and the NSE with an NSE Code of ASTRAZEN.
Its Registered office is at P.B. No. 2483, Off. Bellary Road,,Hebbal Bangalore,Karnataka - 560024.
Their Registrars are Integrated Enterprises (India) Ltd.